Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. In 1 quarter with no in-house report, the figure is what its outside firms reported being paid. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodCoherus Biosciences reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 2 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Government Issues8/8
- Health Issues8/8
- Medicare/Medicaid8/8
Bills named in the filings 3 bills, this period
From the filings
“Issues related to federal drug reimbursement and domestic manufacturing policy.”
“Issues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Issues related to the procurement of the medicine Udenyca”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- OMB
- White House Office
- CMS
- DOC
- DOD
- Energy
- EOP
- FDA
- HHS
- NSC
- 7 more
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Coherus Biosciences, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 6 sitting members of Congress and 1 other candidate in 2025–26.
See every candidate and member Coherus Biosciences gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in